Solage is a drug owned by Almirall Llc. It is protected by 2 US drug patents filed in 2013 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Aug 24, 2020. Details of Solage's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
| US6353029 | Storage stable tretinoin and 4-hydroxyanisole containing topical composition |
Aug, 2020
(4 years ago) |
Expired
|
| US5194247 | Synergistic skin depigmentation composition |
Dec, 2013
(11 years ago) |
Expired
|
US patents provide insights into the exclusivity only within the United States, but Solage is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Solage's family patents as well as insights into ongoing legal events on those patents.
Solage's Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Solage's generic launch date based on the expiry of its last outstanding patent is estimated to be Aug 24, 2020 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Solage Generics:
There are no approved generic versions for Solage as of now.
About Solage
Solage is a drug owned by Almirall Llc. It is used for treating hyperpigmentary disorders. Solage uses Mequinol; Tretinoin as an active ingredient. Solage was launched by Almirall in 1999.
Approval Date:
Solage was approved by FDA for market use on 10 December, 1999.
Active Ingredient:
Solage uses Mequinol; Tretinoin as the active ingredient. Check out other Drugs and Companies using Mequinol; Tretinoin ingredient
Treatment:
Solage is used for treating hyperpigmentary disorders.
Dosage:
Solage is available in solution form for topical use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| 2%;0.01% | SOLUTION | Discontinued | TOPICAL |